Contact Information: Contact Information: Stephen Feldschuh Chief Operating Officer 212-330-8515 Diane Meegan Investor Relations 212-330-8512
Daxor Announces Oklahoma VA Medical Center of Oklahoma City, OK Acquires BVA-100 Blood Volume Analyzer
| Source: Daxor Corp.
NEW YORK, NY--(Marketwire - June 7, 2007) - Daxor Corporation (AMEX : DXR ), a medical
instrumentation and biotechnology company, today announced the receipt of a
signed trial agreement from the Oklahoma City Department of Veterans
Affairs Medical Center (VAMC) of Oklahoma City, Oklahoma.
The Oklahoma City VAMC is a 169-bed facility that serves as a primary,
secondary and tertiary care center for eligible veterans in the greater
Oklahoma City metropolitan area and the western two-thirds of the state,
and two counties in north central Texas. It is a regional referral center
for open-heart surgery and hemodialysis, and has active affiliations with
the University of Oklahoma Medical School. Classified as a Clinical
Referral Level III facility, the Oklahoma City VA Medical Center is a
teaching hospital, providing a full range of patient care services with
state-of-the-art technology.
Daxor's Blood Volume Analyzer BVA-100 will be located within the Oklahoma
VAMC's Nuclear Medicine Department. The BVA-100 will be utilized to
measure, diagnose and treat blood volume abnormalities in various medical
conditions and disease states. A June 2007 article published in the Journal
of Nuclear Medicine Technology discusses the constant estimation by
indirect and often misleading surrogate measurements by clinicians to
determine if a patient is "wet" or "dry." Patients who are "wet" are
treated with diuretics and various fluid removal/restrictive practices,
while "dry" patients receive intravenous fluids or blood transfusions. An
incorrectly diagnosed and treated blood volume abnormality may be extremely
detrimental to a patient's health. Daxor's BVA-100 removes the guess work
of surrogate and indirect estimates by directly measuring a patient's blood
volume to diagnose the blood volume and provide a guide for precise
treatment. Previous published studies in peer reviewed medical journals
have demonstrated improved outcomes when a patient's blood volume is
properly diagnosed and treated.
Other hospitals which have purchased the BVA-100 Blood Volume Analyzer
following a trial agreement are the Mayo Clinic; Cleveland Clinic; and the
VA Medical Center of Puerto Rico. Daxor Corporation manufactures and
markets the BVA-100, the only FDA approved semi-automated Blood Volume
Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single
use diagnostic kit. For more information regarding Daxor Corporation's
Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com.